During sleep, your body repairs cellular damage and replenishes antioxidant stores
Immunofluorescence analysis reveals that GHK-Cu treatment leads to upregulated CD31 expression in scalp tissue, indicating enhanced angiogenesis
That is also our position at CoLaz
As of April 2026, the BPC-157 FDA approval status remains what it has been for the last two decades: no finished-drug approval, no active Investigational New Drug (IND) application, and no FDA-registered human clinical trials
Research applications: telomerase activity in cell cultures, circadian-rhythm and senescence models
A clinician can weigh your symptoms, your labs, and your diagnosis before any peptide is even on the table